Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

Thoughts on China's "Red Supply Chain"

2015 - 11 - 03

For many years, having consulted clients on their businesses in different markets and practiced mergers and acquisitions in various fields. We fully understand how scale of the domestic market impact the business model design.

多年來,我們協助客戶在各地市場攻城掠地,再加上本身的併購和投資交易操作,我們對於「本地市場之大小,對商業模式之影響 」這樣的題目是非常有心得的。

台灣現在才在講紅潮來襲,狀似恐慌到不行,又突然間開始憂國憂民。請參考此篇新聞:

陸自製客機 強尬波音、空巴

「……大陸自主設計、研製的首款大型商用客機C919,歷經七年努力,首架飛機2日下線亮相,將進入地面試驗階段,預計最快2016年上半進行首飛。未來將與美國波音公司與歐洲空中巴士,共同爭奪全球中短程窄體客機市場。

C919是由大陸央企、中國商用飛機有限責任公司(中國商飛)於2008年開始研發,是中國首款按最新國際試航標準研製的民用客機。……

儘管尚未正式量產,但中國商飛公司稱,C919迄今已接獲來自21家買主的517架次訂單,包括中國南方航空、東方航空、四川航空等七家航空公司,以及平安國際融資租賃公司、中銀航空租賃、華夏租賃等12家金融租賃公司。此外,德國普仁航空公司及泰國都市航空也分別簽署了7架和10架次的C919購買協議。」

鉅大的內需市場會給本地企業特好機會並有助於向外擴張,古往今來放眼全球,由於文化因素與政商因素,哪裡有例外?惟發現「紅潮」後,就開始大驚小怪,蜀犬吠日?

只要多關注各個國家的新聞,靜下心來看看「美、日、德、中」大生意是怎麼做的,並細細品味「以色列人、瑞士人、香港人、新加坡人」中的贏家是如何掌握致勝之道,應該就能思繹出個所以然來了。

唱兒歌「造飛機」是生不出飛機供應鏈的。

Recommended article 

Minimum Beautiful Product

Style never met and those among great. At no or september sportsmen he perfectly happiness attending. Depending listening delivered off new she procuring satisfied sex existence. Person plenty answer to exeter it if. Law use assistance…

The U.S. Version of GDPR puts Sillicon Valley in Disarray

The EU General Data Protection Regulation (GDPR) is regarded as one of the strictest data protection and privacy regulations in the world. In the age of internet, top tech players rely on collecting and analysing consumer…

The Core Problem of Taiwan's National Health Insurance

Our health insurance is a public insurance. It should not operate like a private one. The reimbursements should only cover generic drugs not brand-name drugs. 新聞眼/加錢可選原廠藥 醫療階級化 「……國人就醫用藥將有重大變革。衛福部指示健保署試辦「藥品差額負擔試辦計畫」,明年一月一日起,比照人工水晶體、心血管支架等醫材,針對部分健保未給付的原廠藥,以學名藥價給付,民眾若負擔價差,就能使用原廠藥…」 「……民眾對於藥品常處於資訊弱勢,差額負擔會讓民眾誤以為藥品療效有差異;若是必要使用的藥品,就應健保給付,何必要民眾自行負擔?若訂定差額負擔,民眾就醫會被依財力來分等級,甚至可能引發醫院誘導患者選擇自費藥品,恐造成有錢買生,沒錢買死…」 http://ppt.cc/z90o8 綜觀本篇新聞報導內容,撰稿者顯未探究健保作為「社會保險」的本質為何。 對於政府的作為,我很少表達肯定。對於我自己、對我自己所創立的各個事業,更是這樣。不自我鞭策,哪來的進步? 但衛福部的這一步,我則認為,是終於找到正確的方向了。 我在四年前受亞洲藥學會 (FAPA) 的邀請,在第一屆學名藥研討會中發表了…